Table 8.

Correlation between the miPSMA expression score and the other obtained metabolic parameters

T2/T1-quotient (Q) of miPSMA score	Q SUVmax	Q LN_SUVmax	Q SUVmean	Q LN_SUVmean	Q PSMA-TV	Q TL-PSMA	Q LN-TL-PSMA	Q PSA	T2 PSA
All lesions
Correlation coefficient	0.970	0.969	0.970	0.969	0.828	0.903	0.896	0.185	0.472
p value	< 0.001	< 0.001	< 0.001	< 0.001	< 0.001	< 0.001	< 0.001	0.057	< 0.001
Primary tumor
Correlation coefficient	0.874	0.893	0.866	0.885	0.505	0.669	0.666	0.257	0.162
p value	< 0.001	< 0.001	< 0.001	< 0.001	0.012	< 0.001	< 0.001	0.226	0.449
Lymph node metastases
Correlation coefficient	0.968	0.976	0.967	0.975	0.886	0.933	0.931	0.105	0.484
p value	< 0.001	< 0.001	< 0.001	< 0.001	< 0.001	< 0.001	< 0.001	0.442	< 0.001
Bone metastases
Correlation coefficient	0.945	0.951	0.945	0.951	0.873	0.917	0.917	0.132	0.547
p value	< 0.001	< 0.001	< 0.001	< 0.001	< 0.001	< 0.001	< 0.001	0.510	0.003

Q, quotient of T2/T1; LN, liver normalization [value divided by hepatic SUV_mean]. Significant correclation coefficents and their exact p-value are marked bold